Personalized Targeted Inhibitors Treatment in Renal Cell Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Axitinib
Related studies linked through entity extraction aliases.
SLM + Axitinib for Clear Cell RCC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Axitinib in1st Line Treatment for Patients With Advanced or Metastatic Papillary Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Open Label Continuation Study of TRC105 for Patients Who Have Completed a Prior TRC105 Trial
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Phase II Study on Axitinib in Advanced Solitary Fibrous Tumor
- Status
- COMPLETED
- Phase
- PHASE2
VEGF Receptor Tyrosine Kinase Inhibitor Axitinib in Children With Recurrent or Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Post Marketing Surveillance Study to Observe Safety and Efficacy of Inlyta in South Korea
- Status
- COMPLETED
- Phase
- N/A
A Dose Finding Study To Evaluate Safety, Drug Interaction, Tumor Markers Of Axitinib In Combination With MK-3475 In Adult Patients With Previously Untreated Advanced Renal Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1b Study Of Axitinib In Combination With Crizotinib In Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Randomized Phase 2 Trial of Axitinib and TRC105 Versus Axitinib Alone in Patients Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Phase II Study of Axitinib in Metastatic Non-clear Cell Renal Cell Carcinoma Patients Previously Treated With Temsirolimus
- Status
- COMPLETED
- Phase
- PHASE2
Sandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine Carcinomas
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Phase II Study of Axitinib in Patients With Metastatic Renal Cell Cancer Unsuitable for Nephrectomy
- Status
- COMPLETED
- Phase
- PHASE2
NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Adjuvant Axitinib Therapy of Renal Cell Cancer in High Risk Patients
- Status
- TERMINATED
- Phase
- PHASE3
A Randomized Phase II Clinical Trial on the Efficacy of Axitinib as a Monotherapy or in Combination With Lomustine for the Treatment of Patients With Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Pharmacodynamic Study With FLT-PET/CT in Patients With Prostate/Other Solid Malignancies Treated With High Dose Axitinib
- Status
- COMPLETED
- Phase
- PHASE1
Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed by Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Study of Axitinib and Temsirolimus in Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1